NorthStar Medical Radioisotopes has expanded its management team with the appointment of Jean-Noel David, MBA, MS, as Vice President, Operations.

NorthStar Medical Radioisotopes has expanded its management team with the appointment of Jean-Noel David, MBA, MS, as Vice President, Operations. (Photo: Business Wire)


April 24, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic and medical imaging applications, has announced the appointment of Jean-Noel David, MBA, MS, as Vice President, Operations. In this new position, he brings more than 20 years of operational and leadership expertise in the pharmaceutical and life sciences industry to the Company. Mr. David will have company-wide responsibility for Engineering, Manufacturing and Project Management, and report to President and Chief Operating Officer Frank Scholz, Ph.D. 

“NorthStar continues to rapidly expand and advance our programs for therapeutic and diagnostic radioisotopes and radiopharmaceuticals, as well as our new Radiopharmaceutical CDMO/CMO services unit,” said Dr. Scholz. “We’re excited to welcome Jean-Noel to NorthStar. His depth of experience, industry knowledge and demonstrated success in leading development programs and operations will be great assets as we continue to grow across the Company and provide meaningful solutions that can make a positive difference in patients’ lives.“ 

“It’s a great pleasure and opportunity to join NorthStar in this dynamic stage of its development,” said Mr. David. “I’m eager to apply my operations and engineering expertise to help drive the company forward, and look forward to working with this talented team in advancing innovative technologies that can significantly benefit U.S. and global healthcare.” 

Prior to joining NorthStar, Mr. David was Vice President, Transformation and Network Optimization, Cell Gene Therapy, at Catalent, where he oversaw transformation of its Gene Therapy supply chain network. Previous to Catalent, he was Managing Director, North America, with SEQENS CDMO, a global leader in pharmaceutical solutions (CDMO, Generic APIs). Prior to SEQENS, he spent more than eight years with ThermoFisher, Pharma Group and Patheon in roles of increasing responsibility, where he was most recently Senior Director Business Transformation, Patheon. During his tenure with ThermoFisher and Patheon, he led strategic projects related to the integration of ThermoFisher CDMO operations, oversaw the transformation of Patheon’s Biologics unit and led integration efforts for a number of acquisitions. Previous to that, he was a senior management consultant with IBM, and Implementation Director for the Government of Dubai. Mr. David holds an MBA from Emory Business School, Atlanta, Ga. and an MS in Mechanical Engineering from Ecole National Superieure Techniques Avancees, Paris, France. 

For more information: www.northstarnm.com 

Related Radioisotope Content:

NorthStar Medical Radioisotopes Announces Promotion of Jason Vinyard, MBA, MHA, to Vice President, Business Development, Therapeutic Technologies
NorthStar Medical Radioisotopes Announces Supply Agreement with Aktis Oncology, Inc. for Alpha-Emitting Therapeutic Radioisotope Actinium-225 (Ac-225)   
NorthStar Medical Radioisotopes and Convergent Therapeutics Announce Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)     
Update on HFR Reactor Outage – Medical Isotope Supply Returning to Normal     
Update on Unplanned Outage of the HFR Reactor     
SNMMI Issues Alert That HFR Outage Will Impact Isotope Supply    
NorthStar Medical Radioisotopes Advances Focus on Therapeutic and Specialized SPECT Radiopharmaceuticals     
How Nuclear Fusion is Revolutionizing Medical Isotope Production     
FDA Approves Additional Molybdenum-99 (Mo-99) Filling Lines at NorthStar Medical Radioisotopes     
Medical Isotope Industry Opposes Export of Highly Enriched Uranium for IRE     
IBA and NorthStar Medical Radioisotopes Expand Collaboration to Enable Global Availability of Tc-99m  


Related Content

News | Radiology Education

May 24, 2024 — The American Society of Radiologic Technologists (ASRT) has announced that its ASRT Foundation has ...

Time May 24, 2024
arrow
News | Enterprise Imaging

May 24, 2024 — International medical imaging IT and cybersecurity company Sectra’s enterprise imaging solution has been ...

Time May 24, 2024
arrow
News | Artificial Intelligence

May 23, 2024 — NewVue.ai, born from the radiology technology pioneers behind peerVue and recognized as a trailblazer in ...

Time May 23, 2024
arrow
News | Radiation Therapy

May 23, 2024 — RaySearch Laboratories AB and C-RAD announced a collaboration agreement, aiming at jointly developing ...

Time May 23, 2024
arrow
News | FDA

May 22, 2024 — The U.S. Food and Drug Administration (FDA) has issued a recall of the Hologic Inc. BioZorb marker due to ...

Time May 22, 2024
arrow
News | Artificial Intelligence

May 22, 2024 — Lunit, a provider of Artificial intelligence (AI)-powered solutions for cancer diagnostics and ...

Time May 22, 2024
arrow
News | Proton Therapy

May 21, 2024 — IBA, a world leader in particle accelerator technology, announced that it has signed a contract with the ...

Time May 21, 2024
arrow
News | ASTRO

May 17, 2024 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting ...

Time May 17, 2024
arrow
News | Enterprise Imaging

May 16, 2024 — AGFA HealthCare announced that St. Vincent’s Private Hospital in Dublin, Ireland, has chosen to implement ...

Time May 16, 2024
arrow
News | Artificial Intelligence

May 16, 2024 — deepc, the globally recognized digital medicine pioneer and market leader behind the leading AI operating ...

Time May 16, 2024
arrow
Subscribe Now